Description
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
Hide..
Show more..
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
Screenshots
User Rating
App is not rated in Italy yet.
Ratings History
AntiCoagAF Installs
Last 30 days
AntiCoagAF Revenue
Last 30 daysAntiCoagAF Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
257
|
|
Top Paid
|
|
290
|
|
Top Paid
|
|
310
|
|
Top Paid
|
|
387
|
|
Top Paid
|
|
407
|
Keywords
AntiCoagAF Competitors
| Name | Reviews | Recent release | |
|---|---|---|---|
Stroke Prevention in AFib
from @Point of Care
|
0
|
3 months ago | |
AF Stroke Risk
Atrial Fibrillation Evaluation
|
0
|
3 years ago | |
Anticoagulation Manager
|
0
|
1 year ago | |
epTools
Resources for Cardiac EP
|
0
|
9 months ago | |
CoaguSafe - anticoagulanti
|
7
|
5 months ago | |
dark GCS
Glasgow Coma Scale
|
0
|
2 years ago | |
CURRENT Dx Tx Otolaryngology
Entire breadth of ENT topics
|
0
|
1 year ago | |
Easy GCS
N/A
|
0
|
3 weeks ago | |
Aortic Stenosis Evolut™ TAVI
|
0
|
10 months ago | |
XpressO by MoCA
|
0
|
2 months ago |
AntiCoagAF Revenue and Downloads
Gain valuable insights into AntiCoagAF performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
CereScape Pty
- Languages
- English
- Recent version
- 1.3 (2 years ago )
- Released on
- Nov 26, 2013 (10 years ago )
- Also available in
- Australia, Portugal, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Pakistan, Poland, Italy, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, Ukraine, United States, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Azerbaijan, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, Japan, Ecuador, Egypt, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, Indonesia, Ireland, Israel, India, United Arab Emirates
- Last updated
- 5 days ago